NCT05259228View on ClinicalTrials.gov

Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitor in Patients With Chronic Myeloid Leukemia

RecruitingOBSERVATIONAL

Enrollment

40

Participants

Timeline

Start Date

December 1, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Tyrosine Kinase InhibitorPharmacokineticsTherapeutic Drug Monitoring

Trial Locations (1)

100

RECRUITING

National Taiwan University Hospital, Taipei

All Listed Sponsors

lead

National Taiwan University Hospital

OTHER